NIH has released four new SBIR/STTR solicitations (first deadline for all solicitations is September 8, 2026): Parent SBIR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track SBIR awards Parent STTR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track STTR awards SBIR Phase IIB Strategic Breakthrough Award (Clinical Trial Optional) accepts Phase IIB Strategic Breakthrough SBIR awards (for Phase II awardees) SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Clinical Trial Optional) accepts CRP awards (for Phase II awardees) Updated summaries of the research interests, budget waiver topics, and award mechanisms supported by individual Institutes and Centers (ICs) are now housed on the Small Business Funding Considerations and Contacts webpage
Schedule your consult today and experience what it's like to feel seen, supported, and successful on your path to wellness
The settlement requires Totality to take several specific corrective actions, which include refraining from making any statements that suggest the spas products are genuine, FDA-approved Lilly products, and stopping the use of Eli Lilly branding in promoting any of the products
Brain 147 , 444457 (2024)
Our physicians hold current certifications in obesity medicine and specialized weight loss management disciplines